Research study Program year 2024 Source: CMS Open Payments

R250-Px: 89Zr-Tlx250-007: US Eap: Eap

ClinicalTrials.gov NCT06090331

Research payments

$362,690

56 payments

Through program year 2024, $362,690 in research payments was reported against R250-Px: 89Zr-Tlx250-007: US Eap: Eap, across 56 payments, paid by Telix Pharmaceuticals.

Paid by: Telix Pharmaceuticals
ClinicalTrials.gov: NCT06090331

By program year

1 row

Year	Kind	Amount	Payments
2024	Research	$362,690	56

Breakdown

Who paid Research payments · program year 2024

Telix Pharmaceuticals $362,690 56 payments

Who received the money Research payments · program year 2024

Arkansas Urology Research Center LLC Organisation paid for research $98,500 20 payments
University Of Kansas Medical Center Research Institute INC Organisation paid for research $47,200 2 payments
XCancer Omaha LLC Organisation paid for research $43,116 6 payments
Urology Associates Pc Organisation paid for research $42,000 1 payment
University Of Florida Board Of Trustees Organisation paid for research $28,350 1 payment
The University Of Texas Southwestern Medical Center Organisation paid for research $19,024 3 payments
Xcancer Organisation paid for research $17,500 5 payments
Baptist M&S Imaging Center Organisation paid for research $14,000 4 payments
Austin Radiological Association Organisation paid for research $11,000 2 payments
Urology Clinics Of North Texas Organisation paid for research $10,500 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.